Two new tests designed to accelerate the diagnosis of endometriosis are to be made available on the NHS in England and Wales.
The newly National Institution for Health and Care Excellence (NICE)-approved tests, EndoSure and Endotest, are intended to help identify the condition earlier without the need for invasive surgery, according to the organisation. Endotest uses a saliva sample to detect biological markers called microRNAs, which indicate presence of endometriosis. EndoSure measures electrical signals in the gut using sensor pads placed on the abdomen. According to NICE, patients must fast for six to eight hours prior during the 45-minute test and are asked to drink water until full, helping the device record gut activity accurately.
NICE has approved the tests for use over an initial three-year period while further evidence is collected.
Gynecologist and aesthetic practitioner Dr Sima Al Asad said, “If these tests prove accurate and are backed by strong clinical evidence, they could become a valuable tool in both the NHS and private practice. They should not replace detailed consultation or clinical assessment, but they may help identify women who need earlier referral, further investigation or specialist care. No test should replace listening to the patient.”